Cat. #151169
Anti-MBP [TVG MBP 3]
Cat. #: 151169
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: Maltose binding protein.
Class: Monoclonal
Application: ELISA ; IP ; WB
Reactivity: Human papilloma virus
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Lionel Crawford
Institute: University of Cambridge
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-MBP [TVG MBP 3]
- Research fields: Cell biology;Neurobiology
- Clone: TVG MBP 3
- Tool sub type: Primary antibody
- Class: Monoclonal
- Purpose: Marker
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human papilloma virus
- Host: Mouse
- Application: ELISA ; IP ; WB
- Description: TVG MBP 3 is useful for detection and isolation of recombinant MBP fusion proteins
- Immunogen: A single intravenous injection of the maltose binding protein MBP-E2.
- Isotype: IgM
- Myeloma used: P3/NS1/1-Ag4.1
Target Details
- Target: Maltose binding protein.
- Tissue cell line specificity: Mouse
- Target background: TVG MBP 3 is useful for detection and isolation of recombinant MBP fusion proteins
Applications
- Application: ELISA ; IP ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- A deletion in the gene encoding the CD45 antigen in a patient with SCID.
- Hibma et al. 1995. Eur J Biochem. 229(2):517-25. PMID: 7744075.
- The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2.
